Competing risk models to evaluate the factors for time to loss to follow-up among tuberculosis patients at Ambo General Hospital

Abstract Background A major challenge for most tuberculosis programs is the inability of tuberculosis patients to complete treatment for one reason or another. Failure to complete the treatment contributes to the emergence of multidrug-resistant TB. This study aimed to evaluate the risk factors for...

Full description

Saved in:
Bibliographic Details
Main Authors: Daba Bulto Fufa (Author), Tadele Akeba Diriba (Author), Kenenisa Tadesse Dame (Author), Legesse Kassa Debusho (Author)
Format: Book
Published: BMC, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b7ba6270fcfd46a8b5af8c34e8c3376f
042 |a dc 
100 1 0 |a Daba Bulto Fufa  |e author 
700 1 0 |a Tadele Akeba Diriba  |e author 
700 1 0 |a Kenenisa Tadesse Dame  |e author 
700 1 0 |a Legesse Kassa Debusho  |e author 
245 0 0 |a Competing risk models to evaluate the factors for time to loss to follow-up among tuberculosis patients at Ambo General Hospital 
260 |b BMC,   |c 2023-06-01T00:00:00Z. 
500 |a 10.1186/s13690-023-01130-2 
500 |a 2049-3258 
520 |a Abstract Background A major challenge for most tuberculosis programs is the inability of tuberculosis patients to complete treatment for one reason or another. Failure to complete the treatment contributes to the emergence of multidrug-resistant TB. This study aimed to evaluate the risk factors for time to loss to follow-up treatment by considering death as a competing risk event among tuberculosis patients admitted to directly observed treatment short course at Ambo General Hospital, Ambo, Ethiopia. Methods Data collected from 457 tuberculosis patients from January 2018 to January 2022 were used for the analysis. The cause-specific hazard and sub-distribution hazard models for competing risks were used to model the outcome of interest and to identify the prognostic factors associated to treatment loss to follow-up. Loss to follow-up was used as an outcome measure and death as a competing event. Results Of the 457 tuberculosis patients enrolled, 54 (11.8%) were loss to follow-up their treatment and 33 (7.2%) died during the follow up period. The median time of loss to follow-up starting from the date of treatment initiation was 4.2 months. The cause-specific hazard and sub-distribution hazard models revealed that sex, place of residence, HIV status, contact history, age and baseline weights of patients were significant risk factors associated with time to loss to follow-up treatment. The findings showed that the estimates of the covariates effects were different for the cause specific and sub-distribution hazard models. The maximum relative difference observed for the covariate between the cause specific and sub-distribution hazard ratios was 12.2%. Conclusions Patients who were male, rural residents, HIV positive, and aged 41 years or older were at higher risk of loss to follow-up their treatment. This underlines the need that tuberculosis patients, especially those in risk categories, be made aware of the length of the directly observed treatment short course and the effects of discontinuing treatment. 
546 |a EN 
690 |a Competing risks 
690 |a Loss-to-follow-up 
690 |a Hazard functions 
690 |a Tuberculosis 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Archives of Public Health, Vol 81, Iss 1, Pp 1-11 (2023) 
787 0 |n https://doi.org/10.1186/s13690-023-01130-2 
787 0 |n https://doaj.org/toc/2049-3258 
856 4 1 |u https://doaj.org/article/b7ba6270fcfd46a8b5af8c34e8c3376f  |z Connect to this object online.